Overview

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Buprenorphine HCl 8 mg tablet under fasted conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Buprenorphine